Bridewealth and sexual and reproductive practices among women in Harare, Zimbabwe.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3139542)

Published in AIDS Care on June 01, 2010

Authors

Janet M Wojcicki1, Ariane van der Straten, Nancy Padian

Author Affiliations

1: Department of Pediatrics, University of California, San Francisco, CA 94134, USA. wojcicki@gmail.com <wojcicki@gmail.com>

Articles by these authors

Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89

Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med (2015) 9.20

Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22

Hormonal contraception and the risk of HIV acquisition. AIDS (2007) 5.05

Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV (2015) 4.33

Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA (2005) 4.32

Next steps for research on hormonal contraception and HIV. Lancet (2013) 3.70

Early age of first sex: a risk factor for HIV infection among women in Zimbabwe. AIDS (2004) 3.30

Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol (2009) 2.57

Invited commentary: condom effectiveness-will prostate-specific antigen shed new light on this perplexing problem? Am J Epidemiol (2003) 2.45

Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS (2010) 2.23

Combination HIV prevention. Lancet (2008) 2.10

Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials. AIDS Behav (2013) 2.03

Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med (2011) 1.89

HIV incidence among women of reproductive age in Malawi and Zimbabwe. Sex Transm Dis (2006) 1.75

Disentangling contributions of reproductive tract infections to HIV acquisition in African Women. Sex Transm Dis (2009) 1.73

Adherence and its measurement in phase 2/3 microbicide trials. AIDS Behav (2010) 1.60

Acceptability in microbicide and PrEP trials: current status and a reconceptualization. Curr Opin HIV AIDS (2012) 1.55

Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One (2010) 1.55

Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe. AIDS (2007) 1.45

Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial. J Acquir Immune Defic Syndr (2015) 1.32

Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS (2013) 1.25

Does partner selection contribute to sex differences in sexually transmitted infection rates among African American adolescents in San Francisco? Sex Transm Dis (2006) 1.16

Qualitative assessment of venues for purposive sampling of hard-to-reach youth: an illustration in a Latino community. Sex Transm Dis (2004) 1.15

Consistent condom use in married Zimbabwean women after a condom intervention. Sex Transm Dis (2008) 1.13

HIV prevention research: taking stock and the way forward. AIDS (2010) 1.13

The importance of male partner involvement for women's acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav (2011) 1.10

Barrier method preferences and perceptions among Zimbabwean women and their partners. AIDS Behav (2005) 1.10

HIV incidence among non-pregnant women living in selected rural, semi-rural and urban areas in KwaZulu-Natal, South Africa. AIDS Behav (2012) 1.10

Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa. AIDS Behav (2009) 1.08

Vaginal practices and associations with barrier methods and gel use among Sub-Saharan African women enrolled in an HIV prevention trial. AIDS Behav (2010) 1.08

The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS One (2008) 1.06

Patterns and predictors of adherence to diaphragm use in a phase III trial in sub-Saharan Africa: a trajectory analysis. J Acquir Immune Defic Syndr (2009) 1.05

Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe. Contraception (2008) 1.05

Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sex Transm Dis (2008) 1.03

Analyzing Direct Effects in Randomized Trials with Secondary Interventions: An Application to HIV Prevention Trials. J R Stat Soc Ser A Stat Soc (2009) 1.03

Is vaginal washing associated with increased risk of HIV-1 acquisition? AIDS (2006) 1.01

The importance of discreet use of the diaphragm to Zimbabwean women and their partners. AIDS Behav (2006) 1.00

The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav (2008) 1.00

Degrees of disclosure: a study of women's covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa. Soc Sci Med (2009) 0.98

HIV treatment as prevention: how scientific discovery occurred and translated rapidly into policy for the global response. Health Aff (Millwood) (2012) 0.98

African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial. Sex Transm Dis (2011) 0.97

Introducing diaphragms into the mix: what happens to male condom use patterns? AIDS Behav (2005) 0.97

"Male involvement" in women and children's HIV prevention: challenges in definition and interpretation. J Acquir Immune Defic Syndr (2011) 0.97

User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa. AIDS Care (2011) 0.95

Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding". AIDS Behav (2015) 0.95

Duet for menstrual protection: a feasibility study in Zimbabwe. Contraception (2009) 0.95

Sharing the trousers: gender roles and relationships in an HIV-prevention trial in Zimbabwe. Cult Health Sex (2012) 0.94

Feasibility of a breath test for monitoring adherence to vaginal administration of antiretroviral microbicide gels. J Clin Pharmacol (2013) 0.93

Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention. Contraception (2011) 0.92

The obligation to provide antiretroviral treatment in HIV prevention trials. AIDS (2007) 0.92

An acceptability and safety study of the Duet cervical barrier and gel delivery system in Zimbabwe. J Int AIDS Soc (2010) 0.92

A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe. Contraception (2007) 0.91

A comparison of four condom-use measures in predicting pregnancy, cervical STI and HIV incidence among Zimbabwean women. Sex Transm Infect (2009) 0.90

"Come back when you're dying:" the commodification of AIDS among California's urban poor. Soc Sci Med (2002) 0.89

Fully integrated e-services for prevention, diagnosis, and treatment of sexually transmitted infections: results of a 4-county study in California. Am J Public Health (2014) 0.89

Evaluation of HIV prevention programmes: the case of Avahan. Sex Transm Infect (2010) 0.89

Female condom uptake and acceptability in Zimbabwe. AIDS Educ Prev (2008) 0.88

Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg, South Africa. BMC Womens Health (2014) 0.87

Intimate partner violence and condom and diaphragm nonadherence among women in an HIV prevention trial in southern Africa. J Acquir Immune Defic Syndr (2013) 0.86

Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa. Eur J Contracept Reprod Health Care (2009) 0.85

The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2. Sex Transm Infect (2011) 0.83

Association of negotiation strategies with consistent use of male condoms by women receiving an HIV prevention intervention in Zimbabwe. AIDS (2003) 0.82

Could home sexually transmitted infection specimen collection with e-prescription be a cost-effective strategy for clinical trials and clinical care? Sex Transm Dis (2015) 0.82

Paying to prevent HIV infection in young women? Lancet (2012) 0.82

Predictors of incident herpes simplex virus type 2 infections in young women at risk for unintended pregnancy in San Francisco. BMC Infect Dis (2007) 0.82

Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda ( 2000, 14:2371-2381). AIDS (2002) 0.81

What the better half is thinking: A comparison of men's and women's responses and agreement between spouses regarding reported sexual and reproductive behaviors in Rwanda. Psychol Res Behav Manag (2009) 0.81

Project Eban: a giant step forward. J Acquir Immune Defic Syndr (2008) 0.81

Impact of learning HIV status on contraceptive use in the MIRA trial. J Fam Plann Reprod Health Care (2011) 0.80

A qualitative study of obstacles to diaphragm and condom use in an HIV prevention trial in sub-Saharan Africa. AIDS Educ Prev (2012) 0.79

Establishing a continuum of care between HIV prevention trials and public healthcare systems: the MIRA Standard of Care program. Clin Trials (2010) 0.78

Changes in sexual risk behavior before and after HIV seroconversion in Southern African women enrolled in a HIV prevention trial. J Acquir Immune Defic Syndr (2011) 0.78

Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS (2017) 0.78

Disproportionate impact of sexually transmitted diseases on women. Emerg Infect Dis (2004) 0.77

Diaphragm used with replens gel and risk of bacterial vaginosis: results from a randomized controlled trial. Infect Dis Obstet Gynecol (2012) 0.76

Examining the determinants of sexual violence among young, married women in Southern India. J Interpers Violence (2012) 0.76

"It's inside my body and it's mine". AIDS (2017) 0.75